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Background: Studies of the mechanisms by which
signals are transmitted from receptor tyrosine kinases
would be facilitated by a way of monitoring events at the
single-cell level. We have explored how luciferase imag-
ing can be used to examine the role of specific signalling
pathways in insulin-stimulated gene expression. The
analysis of luciferase expression in single cells has pre-
viously been hampered by the insensitivity of existing
methodologies and the lack of a way of monitoring
quantitatively, and independently, more than one pro-
moter within the same cell. We have developed a tech-
nique for examining the dynamics of insulin-stimulated
AP-1-dependent transcription in single living cells, and
have explored the signalling pathway involved.
Results: Luciferase and aequorin gene expression were
examined in single living cells with a high-sensitivity
photon-counting camera. The technique involved the co-
microinjection of luciferase- and aequorin-based reporter
plasmids directly into the cell nucleus, and the subsequent
analysis of luminescence in the presence of luciferin and
coelenterazine, respectively. The method is quantitative
and allows insulin-stimulated gene expression to be moni-
tored in real time. We found that insulin promoted a sub-
stantial increase in the expression of a luciferase gene
under the control of the AP-1-binding site from the col-
lagenase gene promoter. Aequorin expression, under the
control of a cytomegalovirus promoter, was unaffected by
insulin. The effect of insulin on luciferase expression was
specifically blocked by overexpression of either the mito-
gen-activated protein (MAP) kinase phosphatase CL100,
or the dominant-negative mutant MAP kinase kinase,
MEKS21 7 /2 2 1A.
Conclusions: Microinjection coupled with luciferase
imaging allows hormone-regulated gene expression from
relatively weak promoters to be monitored in single living
cells. We have used this method to demonstrate that
MAP kinase plays a central role in the ability of insulin to
stimulate AP-1-dependent gene transcription.
Current Biology 1995, 5:890-899
Background
The use of heterologous reporter genes, such as chlor-
amphenicol acetyltransferase (CAT) and firefly luci-
ferase, has revolutionized studies of the mechanisms
involved in transcriptional regulation [1,2]. However,
these studies generally require the transient or stable
transfection of cell populations with promoter-reporter
constructs, followed by cell lysis and subsequent bio-
chemical analysis of the activity of the reporter protein.
This type of approach only provides an averaged mea-
sure of transcriptional activity in the cell population and
gives no information about the changes occurring within
single cells. This problem can .be partially circumvented
by fixing and permeabilizing the cells for the immuno-
histological analysis of reporter gene expression, but this
only provides semi-quantitative information. More
importantly, neither method allows real-time analysis of
reporter gene activity in vivo. In an attempt to overcome
these problems, we have devised a method that allows
the monitoring of gene expression in single cells in real
time, and applied it to the study of insulin-regulated
gene expression.
Insulin stimulates the collagenase promoter, an effect
mediated by a single 12-O-tetradecanoylphorbol-13-ace-
tate (TPA)-response element, TGA(G/C)TCA, which
acts as binding site for the transcription factor AP-1 [3].
AP-1 is a heterodimer of c-Fos and c-Jun (see [4] for
review). The collagenase promoter can confer insulin-
inducible expression upon heterologous reporter genes
such as CAT and luciferase [3]. The mechanism by which
insulin increases the transcriptional activity of AP-1 has
not previously been addressed directly.
The amino-terminal domain of c-Jun has been reported
to be phosphorylated in vitro on serine residues 63 and 73
by the mitogen-activated protein (MAP) kinase isoforms,
Erkl and Erk2 [5], as well as by the stress-activated MAP
kinase (SAPK) and Jun N-terminal kinase NK) [6,7],
resulting in an increase in its transcriptional activity.
Insulin also rapidly increases c-fos transcription [8], which
may also be mediated by MAP kinase [9], and which
could itself lead to an increase in AP-1 activity. However,
the involvement of MAP kinase in the activation of AP-1
by any receptor tyrosine kinase-mediated pathway has
not yet been directly proven.
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Erkl and Erk2 are rapidly activated by insulin (as well as
other growth factors and neurotrophins) [10-12]. This
activation is dependent on phosphorylation by MAP
kinase kinase (or MEK), a dual specificity protein kinase
which phosphorylates MAP kinases on the threonine
and tyrosine residues in the conserved sequence Thr-
Glu-Tyr within their regulatory domains (residues
192-194 in Erkl, and 183-185 in Erk2). Phosphoryla-
tion of both residues is required for MAP kinase activa-
tion [11,12]. MEK itself is phosphorylated and activated
by Rafl on two serine residues (at positions 217 and
221) [13]. Substitution of these serine residues with
alanines generates a dominant-negative mutant form
of MEK, MEKS2 17/22 1A, which blocks nerve growth
factor-stimulated neurite outgrowth in PC12 cells and
transformation of NIH3T3 cells [14].
MAP kinase can be inactivated by a family of dual speci-
ficity threonine/tyrosine phosphatases, which includes
human CL100 [15], its murine homologue 3CH134
[16], and PAC-1 [17]. CL100 is more than 10 000-fold
more active towards phosphorylated MAP kinase than to
a number of other phosphotyrosine- and phosphothreo-
nine/phosphoserine-containing proteins and peptides
[18]. These dual specificity MAP kinase phosphatases
selectively dephosphorylate MAP kinase when overex-
pressed in cells [16,17]. Furthermore, expression in intact
cells of an enzymatically inactive mutant form of
3CH134 - 3CH134C2 5 8s, in which cysteine residue
258 has been substituted by serine - promotes its tight
association with phosphorylated MAP kinase [16] and,
therefore, may also interfere with normal Erkl/Erk2
function. It is not known, however, whether these dual
specificity phosphatases are responsible for the rapid
return of MAP kinase activity to basal levels that is often
seen after initial stimulation by growth factors. Wu et al.
[19] and Alessi et al. [20] have both reported evidence
that the rapid inactivation phase is independent of CL 100.
Expression of the luciferase gene has previously only
been monitored in intact cells when under the control of
strong viral promoters [21-23]. We have now developed
a method that allows highly quantitative and non-inva-
sive monitoring of the activity of the growth factor-reg-
ulated collagenase promoter. The method is based on
the combined use of two well-characterized photopro-
teins, luciferase and aequorin, which emit light only in
the presence of their respective co-factors, luciferin and
coelenterazine/Ca 2 + [2,24,25]. Using this method, we
have found that insulin-stimulated collagenase promoter
activity (assayed using luciferase as a reporter) is specifi-
cally blocked upon overexpression of either CLI00
or MEKS2 17 /22 1A. The transcriptional activity of a con-
stitutive promoter was simultaneously monitored (using
aequorin as a reporter) and found not to be altered by
the presence of insulin, CL100 or MEKs 2 17 /2 2 1A. The
data strongly imply that MAP kinase has a direct role in
insulin signalling. This method should have wide appli-
cation to real-time time studies of gene expression and
its regulation.
Results
Analysis of insulin-stimulated luciferase gene expression in
single cells
We first cloned a fragment of the human collagenase
gene promoter, containing a single TPA-response ele-
ment (TRE), upstream of the firefly luciferase gene to
produce the plasmid designated pCol.Luc. In preliminary
experiments, CHO.T cells, which have about 5 x 10 5
human insulin receptors per cell, were transiently trans-
fected with pCol.Luc and treated with insulin. The
results showed that the effect of insulin on collagenase
promoter activity was largely mediated via the TRE for
two reasons. Firstly, insulin stimulated to similar extents
the activity of a minimal promoter, with just five
repeated TRE sequences, and the collagenase promoter
(data not shown). Secondly, the level of insulin-stimu-
lated expression of luciferase under the control of a colla-
genase promoter lacking the TRE was less than 1 % of
that produced using the native collagenase promoter
(G.A.R., T. Sood andJ.M.T., unpublished observations).
The pCol.Luc plasmid was microinjected into the nuclei
of single CHO.T cells, which were then incubated for
16 hours in the absence or presence of insulin. As
shown in Figure la, subsequent imaging of the cells in
the presence of 1 mM luciferin, using an intensified
photon-counting charge-coupled device (CCD) cam-
era, revealed that insulin treatment resulted in a dramatic
increase in the luminescence of individual cells. As the
CCD camera is capable of discriminating single photon
events, the degree of luminescence can be quantified
accurately. Furthermore, the signal:noise ratio of the
camera is very low. For example, in a typical experi-
ment, with a data acquisition period lasting 15 minutes,
the background photon count detected within an area
of about 50 Rtm2 (equivalent to the area of a CHO.T
cell) was 0.71 ± 0.35 (mean ± S.E.M.; n = 7 areas).
When CHO.T cells were microinjected with pCol.Luc
and incubated for 16 hours in the presence of insulin,
the luminescence was 771 135 photons per 15 min-
utes per cell (n = 36 cells); in the absence of insulin the
luminescence was 20.5 + 4.2 photons per 15 minutes
per cell (n = 9 cells).
We next examined the time course of insulin-stimulated
luciferase expression in single cells. Cells microinjected
with pCol.Luc were immediately incubated in the con-
tinuous presence of insulin and luciferin at 37 °C.
Insulin-stimulated luciferase expression could be moni-
tored in real time on the microscope stage (Fig. lb).
Again, the degree of luminescence of each cell could be
accurately quantified and plotted (Fig. c). Luminescence
could be detected in some cells after 2-4 hours, and
maximal expression was reached in most cells after
20-24 hours (Fig. lb,c; and data not shown). Neither
luciferase expression nor the cofactor luciferin had any
apparent toxic effect on the cells, which continued to
divide (Fig. lb, arrowhead) and exhibit motility on the
tissue culture dish (compare images at 12 and 14 hours).
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The quantification of the data presented in Figure 1c
revealed considerable heterogeneity in the time course of
response of individual cells. The cause of this heterogene-
ity remains to be established but, because the cells were
not synchronized, it may be related to cell-cycle effects.
In contrast to these experiments, expression of luciferase
could not easily be detected in single cells that were
stably or transiently transfected with pCol.Luc using
either the DEAE-dextran or electroporation protocols.
This presumably reflects the higher plasmid copy number
than can be achieved by direct microinjection. We have
found that the level of luciferase expressed is closely pro-
portional to the strength of promoter in the microin-
jected construct. For example, when CHO.T cells were
microinjected with identical concentrations of constructs
containing the luciferase gene, either under the control
of the collagenase promoter or tandem serum response
elements (SREs), the ratio of luciferase produced in the
presence of insulin was 7:1 (collagenase:SRE). This com-
pares with a ratio of 9:1 when cells were transiently
transfected with these same reporter plasmids and stan-
dard luminometer-based luciferase assays were performed
on the cell extracts.
Effect of CL100 and MEKs 217/2 21A on insulin-stimulated
collagenase promoter activity
CHO.T cells were co-microinjected with pCol.Luc and
either a plasmid (pcDNAIneo.CL100) containing the
CL100 gene under the control of the strong and consti-
tutively active cytomegalovirus (CMV) promoter, or the
control vector (pcDNAIneo). After 16 hours incubation
in the presence of insulin, luciferase luminescence was
imaged (see Fig. 2a) and quantified as described above. In
the presence of CL100, insulin-stimulated luciferase
expression was inhibited by about 75 % - the lumines-
cence of vector-injected cells was 42.1 1.8 photons
min- 1 per cell (n = 30), and the luminescence of CL100-
overexpressing cells was, 10.4 ± 0.6 photons min- 1 per
cell (n = 21). The phosphatase-inactive mutant form
CL100 C258s and wild-type CL100 had quantitatively
similar effects on insulin-stimulated luciferase expression
(Fig. 2a; CL100C2 58 s overexpressing, 4.1 0.6 photons
min- 1 per cell; n = 23). The ability of CL100 to block
the insulin effect was specific to the expression of this
protein as, for example, the CMV-driven expression of
other proteins, such as aequorin (see also below) or
Fig. 1. Regulation of AP-1 activity by insulin in single living cells.
(a) CHO.T cells were microinjected with plasmid pCol.Luc
(0.4 mg ml-1 and then incubated in the absence or presence of
100 nM insulin as shown. The image represents a 15 min data
collection period. (b) Cells were microinjected with pCol.Luc
and simultaneously incubated in serum-free Ham's F12 medium
supplemented with 1 mM luciferin and 100 nM insulin. Each
image represents a 30 min data collection period. Note the divi-
sion of the arrowed cell and the motility of its daughter cell. (c)
The number of photons detected from each of the cells shown in
(b) was quantified using the area analysis program (Argus-50 soft-
ware). The plot shows the induction of luciferase as a function of
time in 11 individual cells.
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3-galactosidase (data not shown), had no effect on
insulin-stimulated collagenase promoter activity. Further-
more, as seen in Figure 2b, neither insulin nor CL100
had any effect on the expression of luciferase from a
CMV promoter (which essentially eliminates any effect
of insulin on the translation of luciferase mRNA).
It could be argued that CL100 overexpression had a gen-
erally toxic effect on cells, which could have led to the
decreased effect of insulin on the collagenase promoter
that we observed. As CL100 overexpression had no effect
on luciferase expression from a CMV promoter (Fig. 2b),
this prospect was unlikely. However, in order to eliminate
this possibility, and at the same time to monitor the tran-
scriptional activity of a constitutive promoter, we next
co-injected CHO.T cells with plasmids pCol.Luc and
pCMV.Aqm. This latter plasmid contains the aequorin
gene under the control of the CMV promoter; the
encoded aequorin is targeted to mitochondria by an in-
frame amino-terminal fusion to the signal peptide of
cytochrome c subunit VIII [26]. Aequorin chemilumin-
esces in the presence of its cofactor, coelenterazine, and
micromolar concentrations of Ca2 + ions [25]. Many
extracellular stimuli promote a rise in mitochondrial Ca2+
concentrations to the low micromolar range, significantly
higher than cytosolic Ca2 + concentrations [26,27]. Thus,
aequorin should give a considerably greater photon yield
if targetted to the mitochondrion than if cytosolic.
Initial experiments showed that aequorin expression was
detectable in single cells after a 4 hour pre-incubation
with coelenterazine and treatment with ATP, which
stimulates a transient increase in intracellular Ca2 + upon
stimulation of P2 purinergic receptors (Fig. 3) [28]. The
Fig. 2. CL100 blocks insulin-stimulated AP-1 activity. (a) Cells
were microinjected with 0.4 mg ml- 1 pCol.Luc plus 0.04 mg.ml-1
of either the control vector (pcDNAlneo) or a vector allowing
overexpression of wild-type CL100 or the CL100c2 58s mutant.
Cells were incubated in the presence of 200 nM insulin before
luciferase imaging (15 min data collection period). (b) Cells were
microinjected with 0.4 mg ml-1 pCMV.Luc plus 0.04 mg ml- of
either control vector (pcDNAlneo) or pcDNAlneo.CL100. Cells
were incubated for 16 h in the presence (a) or absence (b) of
2Q0 nM insulin. The data shown are representative of six separate
experiments.
luminescence of cells was highly transitory, being near
maximal at 8-12 seconds and returning to undetectable
levels by 20 seconds (G.A.R. and J.M.T., unpublished
Fig. 3. Measurement of aequorin luminescence in single cells. CHO.T cells were microinjected with pCMV.Aqm (0.4 mg ml-') and incu-
bated for 16 h in serum-free Ham's F-12 medium containing 200 nM insulin and then for 4 h in the additional presence of 2.5 jiM coe-
lentererazine. Cells were then incubated at 37 C in 1 ml modified Kreb's-Ringer bicarbonate and an image taken over a period of
I min. ATP was rapidly added to a final concentration of 20 p.M in a further 1 ml medium during the acquisition of the second image
(1 min data collection period). The final image (1 min data collection period) shows the complete cessation of aequorin luminescence.
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observations). Parallel experiments showed that, in single
fura-2-loaded CHO.T cells, ATP raised the cytosolic
Ca 2+ concentration from a basal level of 141 + 6.5 nM
up to a peak of 360 ± 13.5 nM (mean + S.E.M.; n = 23),
which declined to basal values after about 1 minute.
Responses to ATP were seen in more than 95 % of stim-
ulated cells. This transient response allowed us subse-
quently to image luciferase expression upon the addition
of luciferin (Fig. 4).
In cells co-microinjected with pCol.Luc and pCMV.Aqm,
insulin stimulated the synthesis of luciferase 22-fold
compared to controls, but was without effect on aequo-
rin production in the same cells (Fig. 4). After co-micro-
injecting pcDNAIneo.CL100, insulin induction of luci-
ferase synthesis was inhibited by more than 80 %,
whereas aequorin production was again essentially unal-
tered. Calculation of the luciferase to aequorin ratio in
individual cells confirmed that CL100 overexpression
blocked insulin-stimulated collagenase promoter activity
(and, by inference, the AP-1 complex), whereas non-reg-
ulated promoter activity was largely unaltered (Table 1).
Similarly, overexpression of MEKS2 17/221A also blocked
the ability of insulin to stimulate the activity of the
collagenase promoter in CHO.T cells (Table 2).
We confirmed some of these data by transiently transfect-
ing CHO.T cell populations (Fig. 5). Cells were co-
transfected with pCol.Luc, pSV.CAT (encoding the CAT
reporter under the control of the SV40 promoter) and
Fig. 4. Independent regulation of collagenase and CMV promoter
activities by insulin and CL100 in single cells. Cells were
microinjected with pCol.Luc (0.5 mg ml-), pCMV.Aqm(0.05 mg ml-1) and 0.05 mg.ml-1 of either empty vector(pcDNAlneo) or pcDNAlneo.CL100. The cells were incubated in
the absence (top four panels) or presence (lower four panels) of
200 nM insulin for 16 h, and then for a further 4 h in the simulta-
neous presence of 2.5 [IM coelentererazine. Aequorin lumines-
cence (left four panels) was imaged for 1.5 min following the
addition of 20 M ATP. Luciferin (1 mM) was then added and
luciferase luminescence (right four panels) monitored for an
additional 15 min.
Fig. 5. Insulin-stimulation of collagenase promoter activity is
strongly inhibited by overexpression of wild-type CL100, and par-
tially inhibited by the CL100c258s mutant. CHO.T cells were co-
transfected with 4 g each of pCol.Luc and pSV2.CAT together
with 16 jig of either pcDNAlneo (Vector), pcDNAlneo.CL100
(CL100) or pcDNAlneo.CL1 00C25 8S (CL100C258s), as shown.
Cells were incubated for 24 h, with or without 200 nM insulin,
before extraction and assay of luciferase and CAT activities. Data
are the means ± S.E.M. of three (minus insulin) or four (plus
insulin) independent experiments, each performed in duplicate.
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empty pcDNAIneo vector, and then incubated in the
presence or absence of insulin. Insulin stimulated a
39 ± 4-fold (mean + S.E.M; three separate experiments
performed in duplicate) increase in the luciferase:CAT
activity ratio. Transfection of pcDNAIneo.CL100 or
pcDNAIneo.CL100C 2 58s in place of the vector control
reduced the luciferase:CAT ratio in extracts of insulin-
stimulated cells by 80 2 % and 48 + 5 %, respectively
(mean ± S.E.M; n = 3).
Overexpression of Erkl enhances the effect of insulin on
AP-1 complex activity
CHO.T cells were co-transfected with pCol.Luc and
pSVCAT along with a plasmid encoding hamster Erkl
under the control of the CMV promoter. Overexpression
of wild-type Erkl resulted in an approximately two-fold
increase in the effect of insulin on luciferase expression
(Fig. 6). This phenomenon was not observed upon over-
expression of a kinase-deficient Erkl (ErklT1 92 A; Fig. 6).
Fig. 6. MAP kinase overexpression enhances insulin-stimulated
collagenase promoter activity. CHO.T cells were co-transfected
with 2 Lg each of pCol.Luc and pSV2.CAT plus 8 p.g of either
pcDNAlneo (Vector) or the same vector expressing Erkl or
Erk1T192A. Cells were treated for 24 h with or without 100 nM
insulin and the resulting luciferase and CAT activities were mea-
sured as described in Materials and methods. Data are the means
(+ S.D.) from one experiment, performed in duplicate, which was
representative of three separate experiments.
Overexpression of either kinase-active or kinase-defi-
cient Erkl had no detectable effect on basal luciferase
expression (Fig. 6).
Effects of insulin and CL100 on MAP kinase translocation to
the nucleus
In order to test whether insulin or CL100C 2 5 8s altered
the subcellular distribution of MAP kinase, we
Fig. 7. Insulin and CL100C258s do not
affect MAP kinase subcellular localiza-
tion. CHO.T cells were co-microin-
jected with pEXV.Erk2.myc plus either
(a,b) the control vector pcDNAlneo or
(c) pcDNAlneo.CL100c258 s . Cells were
serum-starved and incubated without
(a) or with (b,c) insulin for 16 h and
then immunostained with anti-Myc
antibody 9E10, as described in Materi-
als and methods. Identical results were
obtained if the cells were stimulated for
3 h with insulin.
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co-microinjected CHO.T cells with a plasmid encoding
Myc-tagged Erk2 (pEXV.Erk2.myc) and either pcDNAI-
neo.CL100C 2 58 s or its control, the vector pcDNAIneo.
Treatment of the cells with or without insulin followed by
fixation, permeabilization and staining with the anti-Myc
antibody 9E10 revealed that neither insulin nor the phos-
phatase-inactive CL100 had any apparent effect on the
distribution of Erkl between the cytosol and nucleus
(Fig. 7). Indeed, the antibody revealed considerable
nuclear reactivity even in the basal state.
Discussion
In this study, we have developed a novel non-invasive and
quantitative assay for monitoring the regulation of tran-
scription by insulin in single living cells. Imaging of fire-
fly luciferase within single living mammalian cells was
previously possible only when luciferase was expressed
under the control of strong viral promoters [21-23]. We
have now extended these studies to show that luciferase
activity can be detected when its expression is controlled
by the relatively weak collagenase promoter (which is
approximately 100-fold weaker than the CMV promoter;
G.A.R. and J.M.T., unpublished observations). More-
over, we have demonstrated that insulin-stimulated luci-
ferase expression can be followed quantitatively in real-
time in living cells. Real-time analysis of luciferase gene
transcription has also been used in conjunction with
an intensified CCD camera (as in our study) to identify
circadian clock mutants of Arabidopsis plants [29].
We have also developed a method that allows the detec-
tion of both luciferase and aequorin when expressed
simultaneously within single living cells. The ability to
quantify the levels of two separate reporter proteins by
photon-counting allows changes in the activity of a regu-
latable promoter to be normalized ratiometrically to that
of a constitutive promoter. Thus, the technique offers
considerable advantages over current, largely non-quanti-
tative, methods of detecting reporter proteins in fixed
and permeabilized cells by immunofluorescence staining.
In the present studies, we have analyzed aequorin lumi-
nescence purely as a measure of promoter activity. How-
ever, the ability to detect Ca2 +-dependent increases in
luminescence from this protein in single cells after its
molecular targeting to a specific intracellular compart-
ment will provide a powerful new approach for the
analysis of intracellular Ca2 + signalling and homeostasis.
Our combined microinjection and luminescence imag-
ing approach can, in principle, be used with an almost
unlimited array of molecular species - DNA, RNA,
peptides, phospholipids, metal ions and so on - that are
capable of modulating the activity of specific proteins in
known signalling pathways. This, in turn, will permit
detailed analysis of the roles that specific signalling path-
ways play in mediating the effects of a variety of extra-
cellular stimuli on transcription, or even translation of
microinjected mRNA species that have regulatable 5'
untranslated regions. The technique is also well suited to
a real-time in vivo analysis of other phenomena, such as
transcriptional regulation during the cell cycle.
We have used this approach to investigate the role of
MAP kinase in insulin signalling to the nucleus in living
mammalian cells. In vivo evidence in favour of a role for
MAP kinase in any action of insulin has hitherto been
lacking. Indeed, MAP kinase activation does not appear
to be sufficient to account for the metabolic effects of
insulin, and so may play a role only in the growth-
promoting effects of the hormone (see [30] for recent
review). Furthermore, up until now there has been a lack
of direct evidence that MAP kinase is involved in the
regulation of transcription by any defined receptor tyro-
sine kinase, although a role for MAP kinases in the action
of v-Ras [31], serum [32] and phorbol esters [17] has
been suggested.
We have addressed this issue by using three different
approaches to modulate MAP kinase activity: first, inacti-
vating Erkl and Erk2 by overexpressing the phosphatase
CL100; second, preventing the activation of Erkl and
Erk2 by overexpressing MEKS2 17/22 1A; and third, by
overexpressing Erkl. When CL100 was overexpressed in
CHO.T cells and assayed using single-cell imaging, it was
found specifically to block insulin-stimulated collagenase
promoter activation without effect on a constitutive,
non-regulated CMV promoter. Similar results were
obtained when collagenase promoter activation was
monitored by transient transfection. Overexpression of
CL100, by microinjection of an expression plasmid, did
not have a generally deleterious effect on the cell,
because the synthesis and luminescence of aequorin,
which is highly dependent on cellular ATP concentra-
tions, was largely unaffected. These results are consistent
with wild-type CL100 blocking the activation of
Erkl/Erk2 by dephosphorylation.
The mutant CL100C2 5 8s also blocked the effect of insulin
on AP-1-dependent gene expression. The inhibitory
effect of CL100C2 58s was more evident when the plasmid
was microinjected into cells than when it was transiently
transfected - this was most likely because microinjection
gave higher levels of cellular CL100 expression. At
present, this possibility cannot be tested because of the
lack of suitable antisera capable of immunostaining CL100
in fixed and permeabilized cells. CL100C2 58s has been
shown to bind Erkl/Erk2 in vivo [16] and consequently
may inhibit kinase activity by preventing the access of
substrate (for example, c-Jun) to the kinase active site.
The alternative possibility - that the mutant phosphatase
may block Erkl/Erk2 translocation into the nucleus - is
unlikely, as the distribution of a microinjected, Myc-
tagged Erk2 between the nucleus and cytosol was not
affected by overexpressing CL100C25 8 s (Fig. 7). Interest-
ingly, unlike other growth factors [33], insulin does not
appear to promote the nuclear translocation of MAP
kinase (Fig. 7), despite a relatively sustained activation of
the enzyme in these cells [34]. Thus, net translocation of
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MAP kinase into the nucleus may not necessarily follow
its activation and, furthermore, may not be required for
the phosphorylation of transcription factors.
It has been shown previously that CL100 exhibits a con-
siderable degree of substrate specificity for Erkl and Erk2
[18]. In order to exclude further the possibility that the
effect of CL100 we observed was due to dephosphoryla-
tion of a protein unrelated to the MAP kinases, we used
MEKS21 7 /2 2 1 A. This protein, which cannot be phospho-
rylated and activated by Raf-1, blocks growth factor acti-
vation of MAP kinases, presumably by sequestering
upstream activators of MEK, and possibly MAP kinases
themselves [14]. Overexpression of MEKS2 17/ 221A did
indeed block insulin-stimulated collagenase promoter
activity. Furthermore, overexpression of Erkl itself
increased the ability of insulin to stimulate the colla-
genase promoter. Taken together, these data strongly
argue for a direct role of MAP kinases in insulin-medi-
ated stimulation of the collagenase promoter
Our results are consistent with those of Sun et al. [31],
which showed that the phosphatase 3CH134 blocked the
stimulation by activated Ras of increased DNA synthesis
and transcription from an SRE. Our results are also con-
sistent with the ability of kinase-inactive Erkl and Erk2
mutants to block the activation of TRE-dependent tran-
scription by thrombin [35], serum or Ha-Ras [32]. In our
experiments, a similar Erkl mutant did not act in a domi-
nant-negative fashion when studied either in transiently
transfected cell populations or in single cells co-microin-
jected with pCol.Luc and pCMV.Aqm (data not shown).
The precise mechanism by which MAP kinase regulates
the collagenase promoter (and, by inference, AP-1 activ-
ity) in vivo is not known. The inhibition of insulin-stimu-
lated AP-1 activity by CL100 is most simply explained if
activated Erkl/Erk2 is required for the phosphorylation
of the transcription factor p62TCF/Elk-1 [9], which
may up-regulate c-fos transcription and lead to an increase
in the mass of AP-1. However, in some cell types,
p62TCF/Elk-1 appears not to play a role in the activa-
tion of c-fos expression by insulin [36]. We cannot rule
out the alternative possibility that MAP kinases phos-
phorylate and consequently activate the amino-terminal
domain of c-Jun [5]. JNK also phosphorylates the tran-
scriptional activation domain of c-Jun; however, this
process is unlikely to play a role in our studies as the JNK
activity in CHO.T cells was unaffected by insulin treat-
ment (G. Welsh and C.G. Proud, personal communica-
tion). Furthermore, JNK is a poor substrate for 3CH134
[31]. Changes in the phosphorylation of inhibitory sites
within the DNA-binding domain of c-Jun by GSK-3
[37] may play a role, because insulin inhibits the activity
of GSK-3 by more than 70 % in CHO.T cells [38] and
this kinase is phosphorylated and inactivated by p90rk,
which is itself activated by Erkl/Erk2 [39].
The recent cloning and expression of the Aequoria
victoria green fluorescent protein (GFP) [40,41], and the
development of mutants with altered light emission prop-
erties [42-44], have provided a possible alternative to
luciferase for real-time monitoring of gene expression in
single cells. GFP requires no added cofactor, which may
provide an advantage over the use of luciferase. Cur-
rently, however, we have only been able to detect GFP
expression in single CHO.T cells when the gene is
placed under the control of the strong CMV promoter
(G.A.R., J. Burrone and J.M.T., unpublished observa-
tions). By contrast, the collagenase promoter is not strong
enough to drive detectable levels of GFP expression.
Furthermore, the signal:noise ratio for luciferase imaging
using the intensified CCD camera (> 2000) is currently
superior to that of fluorescence detection of GFP (< 10)
when the two reporter genes are expressed in CHO.T
cells using identical CMV promoters (G.A.R. and
J.M.T., unpublished observations).
The low levels of GFP fluorescence may be a conse-
quence of the slow rates of chromophore formation at
the low oxygen tensions present inside cultured mam-
malian cells [45]. These problems could limit the suitabil-
ity of GFP as a real-time reporter of gene expression from
weak promoters in single mammalian cells. Our studies
have shown that the luciferase protein has a half-life of
approximately three hours in CHO.T cells .M.T. and
G.A.R., unpublished observation; but see also [22]). Such
a turnover rate will make luciferase a highly suitable
reporter for monitoring rapid changes in gene expression,
for example when using cell-cycle-dependent promoters.
Conclusions
We have developed a non-invasive and quantitative
method for the real-time monitoring of regulated gene
expression in single living cells. Luciferase imaging, cou-
pled with a microinjection approach, provides the only
currently available method that will allow the quantitative
analysis of weak, growth factor- or hormone-regulated
promoter activities in single living cells. We have used
this method to provide the first direct evidence that MAP
kinase has a role in insulin signalling to the nucleus.
Materials and methods
Materials
Amersham International (Amersham, UK) provided 14C-acetyl
CoA. Oligonucleotides were synthesized by the University of
Bristol Molecular Recognition Centre. Beetle luciferin was
from Promega (Madison, Wisconsin, USA) and coelenterazine
from Molecular Probes (Eugene, Oregon, USA). Unless other-
wise stated, all other biochemical reagents were either from
Sigma (Poole, Dorset, UK) or BDH (Poole, Dorset, UK).
Reporter plasmids
The plasmid pCol.CAT, containing the 580 base-pair 5'
region (-517 to +63) of the human collagenase promoter
upstream of the CAT gene [46], was generously provided by
R. Medema. The pCol.Luc plasmid was generated, using
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standard techniques, by amplifying the 580 base-pair upstream
region of the collagenase promoter by PCR, using pCol.CAT
as template. The primer sequences used were 5'-TTTTTAG-
ATCT& 5 17)CAGGCAGCTTAACAA (BglII site underlined),
and 5'-TTTTTAAGCTT(+ 63)TGTCTTCTT-3' (HindlII site
underlined). The resulting 602 base-pair fragment was blunt-
ended using Klenow DNA polymerase and deoxynucleotide
triphosphates, digested with BgllI and HindIII, gel-purified
and subcloned into the polylinker BglII and HindIII sites of the
luciferase vector, pGL2-basic (Promega, Madison, USA).
Automated sequencing (University of Bristol Molecular
Recognition Centre) across the insert demonstrated identity
with the same portion of the original pCol.CAT plasmid.
However, we have noted in the case of both plasmids the pres-
ence of an additional guanosine, 61 base pairs upstream of the
transcriptional start site, which was not previously reported [3].
Plasmid pCMV.Luc corresponds to plasmid pMW16 of White
et al. [22]. The plasmid pSV2.CAT was provided by A. Beckett
and plasmid pCMV.Aqm was a gift of R. Rizzuto.
Expression plasmids
Plasmids containing wild-type CL100 or CL100C2 58s cDNAs
in pT500 were provided by S. Keyse. The CL100 inserts were
subcloned into pcDNAIneo (Invitrogen, San Diego, USA)
using the flanking BamHI-Xhol restriction sites. Plasmid
pcDNAIneo containing the entire coding region of the Chi-
nese Hamster Erkl cDNA or kinase-deficient Erkl T I92 A [35]
were provided by G. L'Allemain. Plasmids containing Myc-
tagged Erk2 [47], wild-type MEK or MEKS217/2 2 1A [14] (all in
the pEXV vector) were provided by C.J. Marshall. Plasmids
used for microinjections were purified on two successive CsCl
gradients according to standard protocols [48]. Plasmids for
transient transfections were purified by QiagenTM Maxi Prep
according to the manufacturers instructions.
Cell culture and microinjection
CHO.T cells (0.4 x 106) were seeded on 60 mm diameter petri
dishes in Ham's F12 medium (Gibco, Paisley, UK) supple-
mented with 5 % (v/v) foetal calf serum (FCS; Gibco), 10 mM
Hepes-NaOH, 200 U ml-1 benzylpenicillin, 100 p.g ml-1
streptomycin and 250 pg ml-' G418, and cultured at 37 C in
an atmosphere of 5 % CO 2. After 24 h, pCol.Luc (in 2 mM
Tris-HCl, pH 8.0, 0.2 mM Na 2EDTA and at the concentra-
tion given in the figure legends), along with other plasmids as
required, were microinjected (0.2-2.0 sec injection time and at
60-300 hPa pressure) into CHO.T cells using an Eppendorf
5171 micromanipulator and 5424 pressure injector with micro-
pipettes (0.2-0.5 pm external diameter) pulled from glass
borosilicate capillaries (GC120F-10; Clark Biomedical Instru-
ments) and an inverted microscope (Zeiss Aviovert 100TV).
Cells were allowed 30 min to recover before incubation with
or without insulin in serum-free Ham's F12.
Cell-luminescence imaging
Cell luminescence was measured using the Zeiss Axiovert
100TV microscope with a 10x and 0.5 NA objective and
a charge-coupled device camera (C2400-20M; Hamamatsu
Photonics, Hamamatsu, Japan) fitted with a two-stage micro-
channel plate intensifier and Argus-50 image analysis system
(Hamamatsu Photonics). Images were collected in the slice and
gravity modes; the latter was used for quantification purposes
[22]. Aequorin luminescence was measured after preincubation
of cells for 4 h the presence of 2.5 I.M coelentererazine (Mol-
ecular Probes). Cells were incubated at 37 C in 1 ml modified
Kreb's-Ringer bicarbonate [27] and a basal image taken for
1 min. ATP was rapidly added to a final concentration of
20 p.M in a further 1 ml medium during the acquisition of a
second image which lasted for 1 min. Luciferase luminescence
was then monitored in the presence of 1 mM beetle luciferin
and image acquisition performed for the time periods indicated
in the figure legends.
Transient transfection of cell populations
CHO.T cells (0.4 x 106) were seeded onto 60 mm dishes and
incubated for 24 h in Ham's F12 medium containing 5 % FCS.
Cells were then transfected for 90 min, using 250 L.g ml-'
DEAE-dextran and the concentrations of DNA given in the
figure legends, in 3 ml serum-free Ham's F12 medium. Cells
were then incubated for 4.5 h in the same medium (minus
DEAE-dextran and DNA), supplemented with 5 % FCS and
100 .M chloroquine, and subsequently for 16-20 h in this
medium containing 0.5 % FCS and no chloroquine. After pre-
incubation for 1 h in serum-free medium, insulin was added
and the culture continued for a further 24 h. Cells were gently
scraped into ice-cold phosphate-buffered saline, and the sus-
pension divided (2:1) to provide samples for CAT and luci-
ferase assays. After sedimenting for 4 min at 3 000 x g, the cells
destined for the CAT assay were resuspended in 60 I1 of
250 mM Tris-HCI, pH 8.0, 5 mM Na 2EDTA, freeze-thawed
3 times, and heat treated at 60 °C for 5 min. CAT activity was
determined as described [49]. Cells for luciferase assay were
resuspended in 25 pl lysiss buffer' (Promega) and enzyme
activity determined using a commercially available kit
(Promega) and a Lumat LB-9501 luminometer (E.G. and
G. Berthold, Bad Wildbad, Germany). The ratio of luciferase
activity (photon per ig protein) to CAT activity (dpm per p.g
protein) provided a specific measure of collagenase promoter
activity corrected for small variations in transfection efficiency.
MAP kinase immunofluorescence
CHO.T cells (8 x 104 ml-1) were seeded onto glass coverslips
and microinjected with 0.4 mg ml-' of pEXV.Erk2-Myc plus
0.04 mg ml-' of pcDNAlneo or pcDNAIneo.CL100C 2 58s The
cells were incubated for 24 h in Ham's F12 medium containing
5 % FCS and then serum-starved for 2 h prior to incubation for
30 min with 200 nM insulin. The cells were fixed and perme-
abilized in methanol, blocked with 2 % bovine serum albumin
in phosphate-buffered saline and incubated with monoclonal
primary anti-Myc antibody 9E10 (1 mg ml- l [50]) followed by
staining with tetramethylrhodamine isothiocyanate-conjugated
goat-anti-mouse immunoglobulin G (1:100; Sigma).
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